Novel Diagnostic and Therapeutic Strategies with Genetically Engineered Human Antibodies
Tóm tắt
Human antibodies can be generated by recombinant technology. The human immunoglobulin repertoire can be tapped in an effective manner by the so called V gene phage display technology. Using this technique the genes encoding the variable domains of an antibody of interest can be captured from the B cell repertoire. With these V genes tailor‐made immune recognition molecules can be obtained by a ‘design and build’ strategy. These novel developments will lead to the introduction of a manifold of antibody based therapies into the clinic in coming decades. Recombinant antibody technology also provides unique opportunities to study the molecular structure of antibody variable domains against blood cell antigens. Such studies might possibly lead to the development of new therapies for antibody mediated blood cell destruction.
Từ khóa
Tài liệu tham khảo
Griffin H.M., 1995, A human monoclonal antibody specific for the leucine‐33 (PlA1, HPA‐1a) form of platelet glycoprotein IIIa from a V gene phage display library, Blood, 86, 4430, 10.1182/blood.V86.12.4430.bloodjournal86124430
Silberstein L.E., 1991, Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens, Blood, 78, 2372, 10.1182/blood.V78.9.2372.2372
Pascual V., 1991, Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4–21 gene segment is responsible for the major cross‐reactive idiotype, J Immunol, 146, 4385, 10.4049/jimmunol.146.12.4385
Schutte M.E., 1993, VH4.21‐encoded natural autoantibodies with anti‐i specificity mirror those associated with cold hemagglutinin disease, J Immunol, 151, 6569, 10.4049/jimmunol.151.11.6569
Kumpel B.M., 1995, Human Rh D monoclonal antibodies (BRAD‐3 and BRAD‐5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D‐ volunteers, Blood, 86, 1701, 10.1182/blood.V86.5.1701.bloodjournal8651701
Boucher G., 1997, Restricted use of cationic germline V(H) gene segments in human Rh(D) red cell antibodies, Blood, 89, 3277, 10.1182/blood.V89.9.3277
Williamson L.M., 1995, Determination of the natural history of neonatal alloimmune thrombocytopenia (NAITP) by antenatal screening, Blood, 86, 538a
Valentin N., 1995, Involvement of the cysteine‐rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response, Blood, 85, 3028, 10.1182/blood.V85.11.3028.bloodjournal85113028
Mollison P.L., 1997, Blood transfusion in clinical medicine
Gengozian N., 1980, IgG+ platelets in the marmoset: their induction, maintenance, and survival, Blood, 55, 885, 10.1182/blood.V55.6.885.885
Gengozian N., 1981, Antibodies selectively reactive to autologous and host‐type platelets are obtained following interspecies immunizations in marmosets, Clin Exp Immunol, 43, 128
Kabat H., 1991, Sequences of proteins of immunological interest